Taken claim by claim, the nine bathing studies support less together than any single abstract suggests, and this MN504 Unit 7 literature synthesis shows where the support stops. Searches like "mn 504 unit 7 assignment example", "mn504 unit 7 sample" and "mn504 unit 7 example" land here.
Chlorhexidine Bathing Beyond the Intensive Care Unit: A Claim-Based Synthesis of the Evidence for Adults With Central Lines on an Oncology Unit
[Student Name]
Purdue University Global
MN504: Evidence-Based Practice
Unit 7 Assignment
[Instructor Name]
[Date]
The oncology unit is a composite. All studies cited are published sources listed in the references; the local quality report is internal and unpublished.
Introduction
The project's PICOT question compares daily 2% chlorhexidine cloths with the basin baths the unit gives now, for oncology inpatients whose central venous catheters put them at risk, and measures line infections over six months. The evidence table in Unit 5 rated nine sources for level, quality and fit. This synthesis organizes them by claim. Each section states a claim, the studies that bear on it, how consistent they are, how directly they apply to our population, and a confidence label: consistent, suggestive or unresolved. Consistent means several sources of adequate quality point the same way. Suggestive means the evidence points one way but rests on few sources, a subgroup or a weak design. Unresolved means the sources conflict or are too sparse to judge. Organizing by claim rather than by study makes it possible to see that the same study can support one claim strongly and another only weakly, which a study-by-study summary would hide.
Claim 1: Daily Chlorhexidine Bathing Lowers Bloodstream Infection in Adult Intensive Care
In a cluster-randomized crossover trial across intensive care and bone marrow transplant units, units using daily chlorhexidine cloths saw fewer new resistant organisms and fewer bloodstream infections acquired in hospital (Climo et al., 2013). A trial sequential meta-analysis of intensive care trials concluded that chlorhexidine bathing is associated with fewer health care-associated infections and that the accumulated evidence is sufficient for that conclusion (Frost et al., 2018). One pragmatic single-center crossover trial found no significant reduction in a combined infection outcome (Noto et al., 2015), a reminder that effects vary with baseline rates and practice. Consistency: largely consistent, with one null trial. Directness: low, because these patients were critically ill and bathed by staff. Confidence: consistent, for intensive care.
Claim 2: Outside Intensive Care, Bathing Everyone Has Not Been Shown to Work
The largest trial outside intensive care randomized 53 hospitals' general medical and surgical units to daily chlorhexidine bathing, with nasal decolonization for carriers of resistant organisms, or to routine bathing. It found no significant reduction in resistant organism cultures or all-cause bloodstream infection across all patients (Huang et al., 2019). Consistency: a single large, high-quality trial. Directness: moderate, because these were adult inpatients on general units, although not oncology units. Confidence: consistent, and it cuts against a bathe-everyone policy. This claim is placed second on purpose. A proposal that ignored this trial would be arguing against the best non-intensive-care evidence available.
Claim 3: Patients With Central Lines on General Units May Benefit
The same trial reported, in a post hoc analysis, that among patients with medical devices, including central lines, chlorhexidine bathing was associated with fewer resistant organism cultures and fewer bloodstream infections (Huang et al., 2019). A quality report kept internally by a sister oncology unit in our system reported a post-bathing rate of 1.08 per 1,000 line days against 2.34 before, but its interval crossed 1 and chlorhexidine dressings were introduced during the same period. Consistency: two sources pointing in the same direction. Directness: high for the internal report, moderate for the trial subgroup. Confidence: suggestive. This is where the proposal will stand, and its evidence is thinner than the evidence behind claim 1: a subgroup finding not specified in advance, and a local report that cannot separate bathing from a co-intervention. Two kinds of evidence would strengthen it: a trial on oncology or other non-intensive-care units that specified patients with central lines in advance, and a local pilot that measured bathing adherence and recorded every other practice change during the same months.
Claim 4: Harms Are Mostly Minor, With Resistance Unresolved
Skin reactions to chlorhexidine cloths were uncommon and minor in the intensive care trial (Climo et al., 2013). A review of reduced chlorhexidine susceptibility in some organisms argues for antiseptic stewardship and monitoring, although clinical consequences are not established (Kampf, 2016). Consistency: limited data. Directness: moderate. Confidence: unresolved for resistance; consistent that short-term skin harm is minor.
Claim 5: Daily Bathing Can Be Sustained, but Barriers Are Predictable
Interviews with intensive care nurses identified time pressure, product supply and patient refusal as threats to sustaining daily bathing (Musuuza et al., 2017). An evaluation of hospital-wide implementation identified similar workflow and supply barriers on general units (Caya et al., 2015). In the internal report from the sister oncology unit, assistants kept up daily cloth baths for nearly all eligible patients across a full year. Confidence: consistent that bathing is feasible with planning; our own patients' refusal during nausea is a known barrier.
Synthesis Table
Climo et al. (2013): claims 1, 4. Noto et al. (2015): claim 1. Frost et al. (2018): claim 1. Huang et al. (2019): claims 2, 3. Internal report: claims 3, 5. Kampf (2016): claim 4. Musuuza et al. (2017): claim 5. Caya et al. (2015): claim 5. Buetti et al. (2022), the current prevention guidance, supports claim 1 by listing daily bathing of intensive care patients as an essential practice while giving weaker guidance for patients outside intensive care.
Gaps in the Evidence
Three gaps matter for this proposal. First, no trial found in the search was conducted on an oncology unit or restricted to oncology patients, so the effect in patients receiving chemotherapy, many of whom are neutropenic and have ports accessed for days at a time, is inferred from other populations. Second, most trials bathed patients with staff-applied cloths; many oncology inpatients shower independently, and no study found compared chlorhexidine showering with cloth bathing in this group. Third, the harms evidence is short-term. Whether daily chlorhexidine exposure over months of repeated admissions changes skin integrity or organism susceptibility in this population is unknown. These gaps do not argue against a pilot, but they do argue for measuring skin reactions and for asking infection prevention to track chlorhexidine susceptibility in any bloodstream isolates during it.
What the Evidence Will Bear
Taken together, the evidence supports bathing in intensive care, does not support bathing every patient on a general unit, and suggests that adults with central lines outside intensive care may benefit. The recommendation must narrow accordingly. It will propose daily chlorhexidine bathing limited to adults with a central venous catheter on the oncology unit, introduced as a pilot with infection rates, adherence and skin reactions measured, and with every other practice change during the pilot recorded. It will not propose bathing for all patients. If the pilot shows no change in infection rates, that result will be reported as plainly as a positive one, since it would add to the evidence this synthesis found missing.
References
Buetti, N., Marschall, J., Drees, M., Fakih, M. G., Hadaway, L., Maragakis, L. L., Monsees, E., Novosad, S., O'Grady, N. P., Rupp, M. E., Wolf, J., Yokoe, D., & Mermel, L. A. (2022). Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 update. Infection Control and Hospital Epidemiology, 43(5), 553-569. https://doi.org/10.1017/ice.2022.87
Caya, T., Musuuza, J., Yanke, E., Schmitz, M., Anderson, B., Carayon, P., & Safdar, N. (2015). Using a systems engineering initiative for patient safety to evaluate a hospital-wide daily chlorhexidine bathing intervention. Journal of Nursing Care Quality, 30(4), 337-344. https://doi.org/10.1097/NCQ.0000000000000129
Climo, M. W., Yokoe, D. S., Warren, D. K., Perl, T. M., Bolon, M., Herwaldt, L. A., Weinstein, R. A., Sepkowitz, K. A., Jernigan, J. A., Sanogo, K., & Wong, E. S. (2013). Effect of daily chlorhexidine bathing on hospital-acquired infection. New England Journal of Medicine, 368(6), 533-542. https://doi.org/10.1056/NEJMoa1113849
Frost, S. A., Hou, Y. C., Lombardo, L., Metcalfe, L., Lynch, J. M., Hunt, L., Alexandrou, E., Brennan, K., Sanchez, D., Aneman, A., & Christensen, M. (2018). Evidence for the effectiveness of chlorhexidine bathing and health care-associated infections among adult intensive care patients: A trial sequential meta-analysis. BMC Infectious Diseases, 18(1), 679. https://doi.org/10.1186/s12879-018-3521-y
Huang, S. S., Septimus, E., Kleinman, K., Moody, J., Hickok, J., Heim, L., Gombosev, A., Avery, T. R., Haffenreffer, K., Shimelman, L., Hayden, M. K., Weinstein, R. A., Spencer-Smith, C., Kaganov, R. E., Murphy, M. V., Forehand, T., Lankiewicz, J., Coady, M. H., Portillo, L., ... Platt, R. (2019). Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): A cluster-randomised trial. The Lancet, 393(10177), 1205-1215. https://doi.org/10.1016/S0140-6736(18)32593-5
Kampf, G. (2016). Acquired resistance to chlorhexidine: Is it time to establish an "antiseptic stewardship" initiative? Journal of Hospital Infection, 94(3), 213-227. https://doi.org/10.1016/j.jhin.2016.08.018
Musuuza, J. S., Roberts, T. J., Carayon, P., & Safdar, N. (2017). Assessing the sustainability of daily chlorhexidine bathing in the intensive care unit of a Veteran's Hospital by examining nurses' perspectives and experiences. BMC Infectious Diseases, 17(1), 75. https://doi.org/10.1186/s12879-017-2180-8
Noto, M. J., Domenico, H. J., Byrne, D. W., Talbot, T., Rice, T. W., Bernard, G. R., & Wheeler, A. P. (2015). Chlorhexidine bathing and health care-associated infections: A randomized clinical trial. JAMA, 313(4), 369-378. https://doi.org/10.1001/jama.2014.18400
How this MN504 Unit 7 example is structured
Claims, not authors, are the unit of analysis, so no paragraph opens with a citation. Every claim section runs in the same order: the statement, the studies that bear on it, how consistent they are, how directly they apply to adults with central lines on a general oncology floor, and a confidence label of consistent, suggestive or unresolved. Intensive care evidence is strong but indirect, and the synthesis says so rather than borrowing its certainty for the ward. The null ward trial is not buried; it sits second, because a proposal that ignored it would be arguing against the best non-ICU evidence available. Claim three is where the proposal will live, and the paper admits its evidence is thinner than claim one's. The recommendation narrows accordingly: bathing limited to patients who have central lines, piloted and measured, not bathing for everyone.
Get an MN504 Unit 7 example written to your instructions
Bring the studies your evidence table holds, or the table itself, along with the question they answer, the Unit 7 prompt and its rubric. The synthesis is organized by claim, keeps unfavorable findings in view, and ends on a conclusion no broader than your evidence. It comes back in 24-48h, and the first custom sample is free. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
MN504 Unit 7 questions, answered
How is a synthesis different from a literature review summary?
A summary reports each study in turn. A synthesis reports what the studies say together: where they agree, where they conflict, why they might differ, and how far their combined weight reaches. It is organized by finding or claim, and individual studies appear as support. Reading only the topic sentences of a good synthesis should give the argument without any author names.
What should the synthesis do with a study that found no effect?
Include it and weigh it like any other. A well-run null study is evidence, and often important evidence, because it limits how broadly a positive finding can be applied. The synthesis can explain possible reasons for the difference, such as population, dose or outcome definition, without dismissing the result. Leaving it out tends to be noticed and weakens the whole argument.
Is indirect evidence still worth citing?
Yes, labeled as indirect. Evidence from a different setting or population can show that an intervention is biologically plausible and has worked somewhere, which matters. It cannot, however, replace evidence gathered in the setting under discussion. A synthesis that separates the two lets a reader judge how much of the recommendation rests on each.